Wern Chai

Dr. Wern Chai

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2017 in Essays in Biochemistry
Verified
Journal Article
Closed access
PDF file
MAMohsen Arzanlou
Mohsen Arzanlou
WCWern Chai
Wern Chai
Henrietta VenterHenrietta Venter
Henrietta Venter
Gram-negative bacteria are responsible for a large proportion of antimicrobial-resistant infections in humans and animals. Among this class of bacteria are also some of the most successful environmental organisms. Part of this success is their adaptability to a variety of different niches, their intrinsic resistance to antimicrobial drugs and their ability to rapidly acquire resistance mechanisms. These mechanisms of resistance are not exclusive and the interplay of several mechanisms causes high levels of resistance. In this review, we explore the molecular mechanisms underlying resistance in Gram-negative organisms and how these different mechanisms enable them to survive many different stress conditions.

1 August 2017 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
YWYinhu Wang
Yinhu Wang
CCChao Cong
Chao Cong
WCWern Chai
Wern Chai
RDRuiqian Dong
Ruiqian Dong
LJLi Jia
Li Jia
SMShutao Ma
Shutao Ma

5 December 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
WCWern Chai
Wern Chai
JWJonathan J. Whittall
Jonathan J. Whittall
DSDi Song
Di Song
SPSteven Polyak
Steven Polyak
AOAbiodun D. Ogunniyi
Abiodun D. Ogunniyi
Henrietta VenterHenrietta Venter
Henrietta Venter
The bacterial cell division protein, FtsZ, has been identified as a target for antimicrobial development. Derivatives of 3-methoxybenzamide have shown promising activities as FtsZ inhibitors in Gram-positive bacteria. We sought to characterise the activity of five difluorobenzamide derivatives with non-heterocyclic substituents attached through the 3-oxygen. These compounds exhibited antimicrobial activity against methicillin resistant Staphylococcus aureus (MRSA), with an isopentyloxy-substituted compound showing modest activity against vancomycin resistant Enterococcus faecium (VRE). The compounds were able to reverse resistance to oxacillin in highly resistant clinical MRSA strains at concentrations far below their MICs. Three of the compounds inhibited an Escherichia coli strain lacking the AcrAB components of a drug efflux pump, which suggests the lack of Gram-negative activity can partly be attributed to efflux. The compounds inhibited cell division by targeting S. aureus FtsZ, producing a dose-dependent increase in GTPase rate which increased the rate of FtsZ polymerization and stabilized the FtsZ polymers. These compounds did not affect the polymerization of mammalian tubulin and did not display haemolytic activity or cytotoxicity. These derivatives are therefore promising compounds for further development as antimicrobial agents or as resistance breakers to re-sensitive MRSA to beta-lactam antibiotics.

16 February 2023 in International Journal of Pharmacy Practice
Verified
Journal Article
Open access
PDF file
TBTien Ngoc Thi Bui
Tien Ngoc Thi Bui
JJJack Luke Janetzki
Jack Luke Janetzki
WCWern Chai
Wern Chai
VSVijay Suppiah
Vijay Suppiah
Objectives: During the COVID-19 pandemic, Australian community pharmacists delivered a wide range of professional services, including COVID-19 vaccinations. The aim of this study was to understand the reasons for and attitudes of consumers receiving COVID-19 vaccinations from community pharmacists. Methods: A nationwide anonymous online survey recruited consumers above the age of 18 years who had received their COVID-19 vaccinations at community pharmacies between September 2021 and April 2022. Key findings: COVID-19 vaccinations at community pharmacies were positively received by consumers due to their convenience and accessibility. Conclusions: Future health strategies should utilise the highly trained workforce of community pharmacists for wider public outreach.

7 November 2024 in Journal of Pharmacy Practice and Research
Verified
Journal Article
Open access
JJJack Luke Janetzki
Jack Luke Janetzki
WCWern Chai
Wern Chai
TBTien Ngoc Thi Bui
Tien Ngoc Thi Bui
TSTin Fei Sim
Tin Fei Sim
VSVijay Suppiah
Vijay Suppiah
Recent medicine shortages in Australia have significantly impacted pharmacists' professional practice. The inability to provide essential medicines to consumers in a timely manner has increased pharmacist workload whilst attempting to maintain quality patient care during and after the COVID‐19 pandemic. This study aimed to investigate the impact of medicine shortages on the operational responsibilities of community pharmacists, their ability to deliver health care, and the personal impact on community pharmacists. A nationwide anonymous survey was distributed to Australian community pharmacists via the Qualtrics survey platform between April – September 2023. Of the 142 pharmacists who responded to this survey, 89.5% (n = 127) reported having to purchase medicines from sources other than their regular wholesaler on at least a weekly basis in the last 3 months. The same number reported that they frequently needed to substitute medicines because of ongoing shortages. Most pharmacists (n = 128, 90.1%) reported that their workload had been affected by medicine shortages and that their motivation and engagement with work were frequently affected (n = 79, 55.7%). Pharmacists reported taking on additional administrative responsibilities to ensure access to treatment and health care. Current regulatory restrictions regarding the substitution of medicine dosage forms are often implemented only after community pharmacists are affected by medicine shortages. This survey highlights the need for improved awareness of medicine shortages and timely actions to be taken to ensure pharmacist wellbeing and patient access to health care in the face of medicine shortages. Ethics approval was granted by the University of South Australia Human Research Ethics Committee (Reference no.: 205399) and the study conforms with the Australian National Statement on Ethical Conduct in Human Research. Informed consent was obtained from all participants.

6 November 2025 in International Journal of Clinical Pharmacy
Verified
Journal Article
Open access
PDF file
JTJiun Ming Tan
Jiun Ming Tan
KDKatherine Desforges
Katherine Desforges
WCWern Chai
Wern Chai
SPSusanna M. Proudman
Susanna M. Proudman
MWMichael D. Wiese
Michael D. Wiese
EREmily Reeve
Emily Reeve
Introduction Rheumatoid arthritis (RA) is a chronic, inflammatory autoimmune disease. Disease-modifying antirheumatic drugs (DMARDs) are the cornerstone of management and methotrexate is broadly considered as first-line treatment. Gastrointestinal side effects and variable bioavailability however limit adherence to and effectiveness of oral methotrexate, while parenteral methotrexate remains underutilized. Aim To explore RA patients' perspective and their level of acceptance towards parenteral methotrexate and to investigate the barriers and enablers to its use. Method A qualitative study was conducted using semi-structured interviews between May and August 2022. Participants were recruited using convenience and purposive sampling strategy. The Theoretical Framework of Acceptability (TFA) was used to guide the development of the interview guide and data analysis (directed content analysis). Results Twenty-five participants (68% female, 76% with experience using parenteral methotrexate) were interviewed. All seven TFA constructs were found to influence participants’ acceptance of parenteral methotrexate. High acceptance was related to the TFA constructs “perceived effectiveness”, “intervention coherence”, “self-efficacy” and “ethicality”. Experience with disease improvement and gastrointestinal tolerance with parenteral methotrexate was valued by the participants, and understanding these benefits was linked with high acceptability (perceived effectiveness). Participants reported a high level of confidence in using methotrexate injections and adapting to the injection-taking routine (self-efficacy). The user-friendly design of the methotrexate pre-filled syringe, along with the support from healthcare professionals, served as enablers (intervention coherence and ethicality). Minimal opportunity costs (e.g., no major lifestyle sacrifices) further supported acceptability, though some reported initial injection anxiety (affective attitude). Barriers were frequently identified in the “burden” construct, including travel inconvenience and injection-associated cost. Participants without the experience with methotrexate injections expressed the need for further information, particularly regarding the logistical and safety aspects of parenteral methotrexate (intervention coherence). Conclusion Our findings highlighted that patients' comprehension of the benefits of using parenteral methotrexate, confidence in self-administration, healthcare professionals’ support, and the ease of using injections may help optimize treatment acceptability, underscoring the importance of patient’s education from healthcare professionals and the availability of patient-friendly devices.